tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

GYRE Stock Latest News

Gyre Therapeutics Reports Q3 2024 Financial Results and Strategic Updates
Company AnnouncementsGyre Therapeutics Reports Q3 2024 Financial Results and Strategic Updates
1M ago
GYRE
Gyre Therapeutics files $150M mixed securities shelf
PremiumThe Fly
Gyre Therapeutics files $150M mixed securities shelf
1M ago
GYRE
Gyre: Last patient completes trial evaluating F351 for CHB-liver fibrosis
PremiumThe Fly
Gyre: Last patient completes trial evaluating F351 for CHB-liver fibrosis
2M ago
GYRE
Gyre Therapeutics Welcomes Dr. Epstein to Leadership Team
PremiumCompany Announcements
Gyre Therapeutics Welcomes Dr. Epstein to Leadership Team
5M ago
8K
GYRE
Catalyst Biosciences Inc trading resumes
PremiumThe Fly
Catalyst Biosciences Inc trading resumes
5M ago
GYRE
Catalyst Biosciences Inc trading halted, volatility trading pause
PremiumThe FlyCatalyst Biosciences Inc trading halted, volatility trading pause
5M ago
GYRE
Gyre Therapeutics Seeks Compliance Amid Board Reshuffle
Premium
Company Announcements
Gyre Therapeutics Seeks Compliance Amid Board Reshuffle
6M ago
8K
GYRE
NMPA approves Gyre’s avatrombopag maleate tablets for TP associated with CLD
Premium
The Fly
NMPA approves Gyre’s avatrombopag maleate tablets for TP associated with CLD
6M ago
GYRE
Gyre announces publication in Journal of Gastroenterology and Hepatology
PremiumThe Fly
Gyre announces publication in Journal of Gastroenterology and Hepatology
6M ago
GYRE
Gyre Therapeutics Advances with F230 IND Approval in China
PremiumCompany Announcements
Gyre Therapeutics Advances with F230 IND Approval in China
7M ago
8K
GYRE
Gyre Therapeutics gets IND okay from China’s NMPA to evaluate F230 for PAH
PremiumThe Fly
Gyre Therapeutics gets IND okay from China’s NMPA to evaluate F230 for PAH
7M ago
GYRE
Gyre Therapeutics files $150M mixed securities shelf
PremiumThe Fly
Gyre Therapeutics files $150M mixed securities shelf
7M ago
GYRE
Gyre Therapeutics files to sell 1.08M shares of common stock for holders
PremiumThe FlyGyre Therapeutics files to sell 1.08M shares of common stock for holders
7M ago
GYRE
Catalyst Biosciences Inc trading resumes
Premium
The Fly
Catalyst Biosciences Inc trading resumes
7M ago
GYRE
Catalyst Biosciences Inc trading halted, volatility trading pause
Premium
The Fly
Catalyst Biosciences Inc trading halted, volatility trading pause
7M ago
GYRE
Gyre announces addition to Russell 2000 and 3000 Indexes
PremiumThe Fly
Gyre announces addition to Russell 2000 and 3000 Indexes
7M ago
GYRE
Gyre Therapeutics Expands Pulmonary Fibrosis Portfolio
PremiumCompany Announcements
Gyre Therapeutics Expands Pulmonary Fibrosis Portfolio
8M ago
8K
GYRE
Gyre Therapeutics Welcomes New Expertise to Board Team
PremiumCompany Announcements
Gyre Therapeutics Welcomes New Expertise to Board Team
9M ago
8K
GYRE
Gyre Therapeutics expands board of directors with appointment of Nussbaum
PremiumThe Fly
Gyre Therapeutics expands board of directors with appointment of Nussbaum
9M ago
GYRE
Gyre Therapeutics: Annual Financial Results and Future Outlook
PremiumCompany AnnouncementsGyre Therapeutics: Annual Financial Results and Future Outlook
10M ago
8K
GYRE
Gyre Therapeutics presents poster on hydronidone at AASLD Meeting
Premium
The Fly
Gyre Therapeutics presents poster on hydronidone at AASLD Meeting
1y ago
GYRE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >